María Luisa
Torres Durán
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (9)
2024
-
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project
Respiratory Research, Vol. 25, Núm. 1
-
Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
Archivos de Bronconeumologia
2023
-
COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
BMC Health Services Research, Vol. 23, Núm. 1
-
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
The European respiratory journal
-
Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)
Respiratory Research
-
Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
International Journal of COPD, Vol. 18, pp. 1691-1700
-
Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study
Biomedicines, Vol. 11, Núm. 2
2022
-
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
Respiratory Research, Vol. 23, Núm. 1
-
Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
ERJ Open Research, Vol. 8, Núm. 3